Literature DB >> 1815214

Capsaicin-sensitive vagal afferents and CCK in inhibition of gastric motor function induced by intestinal nutrients.

H E Raybould1.   

Abstract

The role of vagal afferent pathways and cholecystokinin (CCK) in mediating changes in gastric motor function after a meal was investigated in urethane-anesthetized rats. Proximal gastric motor function was measured manometrically, and nutrients were infused into an isolated segment of duodenum. Inhibition of gastric motility in response to duodenal infusion of protein (peptone or casein), but not carbohydrate (glucose), was significantly attenuated by administration of the CCK antagonist, L364,718. Selective ablation of vagal afferents by perineural treatment with the sensory neurotoxin, capsaicin, significantly reduced responses to both duodenal protein and glucose. These results suggest that protein in the duodenum decreases proximal gastric motor function via release of CCK and a vagal capsaicin-sensitive afferent pathway. In contrast, glucose acts via a capsaicin-sensitive vagal pathway not involving CCK. Thus separate neural and hormonal mechanisms mediate the effects of different nutrients in the duodenal feedback regulation of gastric motor function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1815214     DOI: 10.1016/0196-9781(91)90207-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.

Authors:  Chunmin C Lo; W Sean Davidson; Stephanie K Hibbard; Maria Georgievsky; Alexander Lee; Patrick Tso; Stephen C Woods
Journal:  Endocrinology       Date:  2014-02-24       Impact factor: 4.736

Review 2.  Neuroendocrine circuits governing energy balance and stress regulation: functional overlap and therapeutic implications.

Authors:  Yvonne M Ulrich-Lai; Karen K Ryan
Journal:  Cell Metab       Date:  2014-03-13       Impact factor: 27.287

3.  Reduction of food intake by cholecystokinin requires activation of hindbrain NMDA-type glutamate receptors.

Authors:  Jason Wright; Carlos Campos; Thiebaut Herzog; Mihai Covasa; Krzysztof Czaja; Robert C Ritter
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-11       Impact factor: 3.619

4.  Human duodenal motor activity in response to acid and different nutrients.

Authors:  M P Schwartz; M Samsom; A J Smout
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

5.  Effect of peripheral administration of cholecystokinin on food intake in apolipoprotein AIV knockout mice.

Authors:  Go Yoshimichi; Chunmin C Lo; Kellie L K Tamashiro; Liyun Ma; Dana M Lee; Denovan P Begg; Min Liu; Randall R Sakai; Stephen C Woods; Hironobu Yoshimatsu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-29       Impact factor: 4.052

Review 6.  ApoA-IV: current and emerging roles in intestinal lipid metabolism, glucose homeostasis, and satiety.

Authors:  Alison B Kohan; Fei Wang; Chun-Min Lo; Min Liu; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-01-15       Impact factor: 4.052

Review 7.  Apolipoprotein A-IV: a protein intimately involved in metabolism.

Authors:  Fei Wang; Alison B Kohan; Chun-Min Lo; Min Liu; Philip Howles; Patrick Tso
Journal:  J Lipid Res       Date:  2015-02-01       Impact factor: 5.922

8.  Nitric oxide mediates mechano- and chemoreceptor-activated intestinal feedback control of gastric emptying.

Authors:  M Orihata; S K Sarna
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

9.  Sensing via intestinal sweet taste pathways.

Authors:  Richard L Young
Journal:  Front Neurosci       Date:  2011-03-03       Impact factor: 4.677

10.  The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release.

Authors:  Alyce M Martin; Emily W Sun; Geraint B Rogers; Damien J Keating
Journal:  Front Physiol       Date:  2019-04-16       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.